WO2025134057 - SOLID STATE FORMS OF TRILACICLIB CITRATE SALT
National phase entry is expected:
Publication Number
WO/2025/134057
Publication Date
26.06.2025
International Application No.
PCT/IB2024/063032
International Filing Date
20.12.2024
Title **
[English]
SOLID STATE FORMS OF TRILACICLIB CITRATE SALT
[French]
FORMES À L'ÉTAT SOLIDE DE SEL DE CITRATE DE TRILACICLIB
Applicants **
ASSIA CHEMICAL INDUSTRIES LTD.
Inventors
MUTHUSAMY, Anantha Rajmohan
SOMASUNDARAM, Meenakshi Sundaram
KAUSHIK, Babita
FERENCZI, Renáta Kertiné
BESENYEINÉ CSILLAG, Kinga Karola
SÓS, Martin
Priority Data
202311087271
20.12.2023
IN
63/730,480
11.12.2024
US
202411098382
12.12.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2047 | |
| EPO | Filing, Examination, Granting | 8113 | |
| Japan | Filing, Examination, Granting | 2061 | |
| South Korea | Filing, Examination, Granting | 1949 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
20,110
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure encompasses solid state forms of Trilaciclib citrate salt, in embodiments polymorphs of Trilaciclib citrate salt, processes for preparation thereof, and pharmaceutical compositions thereof.[French]
La présente divulgation concerne des formes à l'état solide de sel de citrate de trilaciclib, dans des modes de réalisation, des polymorphes de sel de citrate de trilaciclib, leurs procédés de préparation et des compositions pharmaceutiques associées.